4.6 Article

Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria

Journal

ANTIBIOTICS-BASEL
Volume 10, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics10040381

Keywords

avermectins; nontuberculous mycobacteria; Mycobacteroides abscessus; selamectin; milbemycin oxime; repurposing

Funding

  1. Government of Aragon (Gobierno de Aragon y Fondos FEDER de la Union Europea Construyendo Europa desde Aragon)
  2. Canadian Institutes of Health Research [MOP-82855]
  3. European Society of Clinical Microbiology and Infectious Diseases (ESCMID Research Grants)
  4. Government of Aragon, Spain (Gobierno de Aragon y Fondos Feder de la Union Europea Construyendo Europa desde Aragon) [LMP132_18]

Ask authors/readers for more resources

Infections caused by nontuberculous mycobacteria (NTM) are on the rise globally, posing a new global health concern. Despite the complex treatment with multiple drugs, outcomes of NTM disease are often poor.
Infections caused by nontuberculous mycobacteria (NTM) are increasing worldwide, resulting in a new global health concern. NTM treatment is complex and requires combinations of several drugs for lengthy periods. In spite of this, NTM disease is often associated with poor treatment outcomes. The anti-parasitic family of macrocyclic lactones (ML) (divided in two subfamilies: avermectins and milbemycins) was previously described as having activity against mycobacteria, including Mycobacterium tuberculosis, Mycobacterium ulcerans, and Mycobacterium marinum, among others. Here, we aimed to characterize the in vitro anti-mycobacterial activity of ML against a wide range of NTM species, including Mycobacteroides abscessus. For this, Minimum Inhibitory Concentration (MIC) values of eight ML were determined against 80 strains belonging to nine different NTM species. Macrocyclic lactones showed variable ranges of anti-mycobacterial activity that were compound and species-dependent. Milbemycin oxime was the most active compound, displaying broad-spectrum activity with MIC lower than 8 mg/L. Time kill assays confirmed MIC data and showed bactericidal and sterilizing activity of some compounds. Macrocyclic lactones are available in many formulations and have been extensively used in veterinary and human medicine with suitable pharmacokinetics and safety properties. This information could be exploited to explore repurposing of anti-helminthics for NTM therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available